Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.
Zadro Y, Lusque A, Rey H, Cougoul P, Dion J, Graveleau J, Lemarié F, Le Clech L, Orvain C, Domnariu PA, Gourguechon C, Crickx É, Laribi K, Gobert D, Adjoumani L, Berthoux É, Deroux A, Durel M, Ebbo M, Farhi J, Humbert S, Jachiet V, Thomazeau J, Castel B, Begey C, Rieu JB, Deshayes S, Devaux M, Durieu I, Gauthier M, Loirat M, Rivière É, Viallard JF, Martis N, Jeandel PY, Paillassa J, Denis G, Hadj-Khelifa S, Lavigne C, Lifermann F, Andrès E, Dumontet C, Grobost V, Sauvetre G, Mekinian A, Michel M, Godeau B, Ysebaert L, Moulis G, Comont T.
Zadro Y, et al. Among authors: berthoux e.
Am J Hematol. 2025 Sep;100(9):1670-1674. doi: 10.1002/ajh.27754. Epub 2025 Jul 8.
Am J Hematol. 2025.
PMID: 40626616